Rare pediatric disease designation awarded to sickle cell treatment

Sancilio Pharmaceuticals' Altemia capsule was granted rare pediatric disease status by the FDA for the treatment of sickle cell disease in 5- to 17-year-olds. Results from a randomized, double-blind, placebo-controlled multicenter trial are expected by the end of the year.